Genmab’s passion for understanding how antibodies work led to breakthrough insights into the molecular requirements of antibody biology (click here and here for relevant scientific publications). Our drive to innovate inspired us to transform this knowledge into creative, broadly applicable antibody technologies.
- - The DuoBody technology, an innovative platform for the discovery and development of bispecific antibodies, and
- - The HexaBody technology, designed for the creation of potent
therapeutics based on targeted assembly of antibody hexamers at the cell